Evidence map›Paper›PMID 11839806›Full record

ArticleMolecular and cellular biology2002

The B-domain lysine patch of pRB is required for binding to large T antigen and release of E2F by phosphorylation.

Vivette D Brown, Brenda L Gallie

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. P16iScience · 2024
    Article
  3. Article
  4. Review
  5. The human retinoblastoma susceptibility gene (RB1): an evolutionary story in primates.Mammalian genome : official journal of the International Mammalian Genome Society · 2017
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vivette D BrownThe Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, and Department of Molecular and Medical Genetics, University of Toronto, Toronto, Ontario M5G 2M9, Canada.
Brenda L Gallie
Ontario Institute for Cancer Research · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell cycle-dependent, site-specific phosphorylation of the retinoblastoma protein, pRB, is mediated by cyclin-dependent kinases (CDKs) and regulates the binding of pRB to many proteins. We previously showed that the interaction of pRB with E2F on DNA was regulated by the accumulation of phosphate groups on pRB. Here we show that positively charged lysine residues in the B domain of pRB are necessary for the release of pRB from E2F on DNA following phosphorylation by cyclin E-cdk2 kinase. These lysine residues are also important in the binding of the simian virus 40 large T antigen (TAg) to pRB, and mutation of these lysines to arginines alters the dependency of the pRB-TAg interaction on phosphorylation of pRB.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsLysineAcetylationAmino Acid SequenceAnimalsAntigens, Polyomavirus TransformingBinding SitesCyclin EE2F Transcription FactorsGene Expression RegulationHistone Deacetylase 1Histone DeacetylasesHumansMiceMolecular Sequence DataAntigens, Polyomavirus TransformingCell Cycle ProteinsCyclin EDNA-Binding ProteinsE2F Transcription FactorsHDAC1 protein, humanHistone Deacetylase 1Histone DeacetylasesLysineRetinoblastoma ProteinTranscription Factors

Identifiers

PMID11839806
PMCPMC134706
OpenAlexW2127384205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.